Anorectal Function and Clinical Characteristics Associated with Faecal Incontinence in Patients with Crohn's Disease.

BACKGROUND AND AIMS: Faecal incontinence is an important complaint reported by patients with Crohn's disease [CD] and it is associated with several disease-related mechanisms, including anorectal functional disorders. This study aimed to assess the anorectal function and clinical characteristics to identify parameters associated with faecal incontinence in CD patients. METHODS: This is a cross-sectional study of 104 patients with CD, aged 18 years or older, from a referral centre between August 2019 and May 2021. Patients responded to a specific questionnaire, and underwent medical record review, proctological examination and anorectal functional assessment with anorectal manometry. RESULTS: Of the 104 patients, 49% were incontinent. Patients with incontinence had a lower mean resting pressure [43.5 vs 53.1 mmHg; p = 0.038], lower mean squeeze pressure [62.1 vs 94.1 mmHg; p = 0.036] and lower maximum rectal capacity [140 vs 180 mL; p < 0.001]. Faecal incontinence was also associated with disease activity [p < 0.001], loose stools [p = 0.02], perianal disease [p = 0.006], previous anoperineal surgery [p = 0.048] and number of anorectal surgeries [p = 0.036]. CONCLUSIONS: This is the largest reported study describing manometric findings of Crohn's disease patients with and without faecal incontinence. Our results identified an association between faecal incontinence and functional disorders, in addition to clinical features in these patients. Functional assessment with anorectal manometry may help choose the best treatment for faecal incontinence in patients with CD.

Variables associated with progression of moderate-to-severe Crohn's disease.

OBJECTIVE: Determine the variables associated with hospitalisations in patients with Crohn's disease and those associated with surgery, intestinal resection, hospital readmission, need for multiple operations and immunobiological agent use. DESIGN: A cross-sectional study was conducted from 2019 to 2021, using two centres for inflammatory bowel diseases in the Brazilian Public Health System. RESULTS: This study included 220 patients. Only perianal disease was associated with hospitalisation (31.6% vs 13.0%, p=0.012). Stricturing or penetrating behaviour (35.8% vs 12.6%, p<0.001) and perianal disease (45.9% vs 9.9%, p<0.001) were associated with surgery. Ileal or ileocolonic location (80.0% vs 46.5%, p=0.044) and stricturing or penetrating behaviour (68.0% vs 11.2%, p<0.001) were associated with intestinal resection. Steroids use at first Crohn's disease occurrence and postoperative complications were associated with hospital readmission and need for multiple operations, respectively. Age below 40 years at diagnosis (81.3% vs 62.0%, p=0.004), upper gastrointestinal tract involvement (21.8% vs 10.3%, p=0.040) and perianal disease (35.9% vs 16.3%, p<0.001) were associated with immunobiological agent use. CONCLUSION: Perianal disease and stricturing or penetrating behaviour were associated with more than one significant outcome. Other variables related to Crohn's disease progression were age below 40 years at diagnosis, an ileal or ileocolonic disease localisation, an upper gastrointestinal tract involvement, the use of steroids at the first Crohn's disease occurrence and history of postoperative complications. These findings are similar to those in the countries with a high prevalence of Crohn's disease.

Performance and serum parameters of calves (Bos taurus) subject to milk restriction associated with supplementation with 2-hydroxy-4-(methylthio)butanoic acid.

Our aim with this study was to evaluate the consumption, performance, quantitative characteristics of carcasses, biochemical profile, plasma levels of ghrelin and leptin, expression of the receptor for ghrelin (GHS-R1a) in the hypothalamus and duodenum, and the number of goblet cells in the duodenum of calves subjected to milk volume restriction and supplemented with 2-hydroxy-4-(methylthio)butanoic acid (HMTBa). We used 21 Holstein mixed-breed calves, aged between 3 and 15 d with an average weight of 36.8 kg, and housed in pens with troughs for hay, concentrate, and water. The study included two consecutive experimental periods (first period [P1] and second period [P2]) of 21 d each, with 7 d of adaptation to the diet and facilities. The calves were distributed in a completely randomized design in three treatments with seven repetitions. 1) Control: 6 liters of milk/d during P1 and 6 liters of milk/day during P2; 2) RES (milk restriction): 3 liters of milk/day during P1 and 6 liters of milk/day during P2; and 3) RES + HMTBa: 3 liters of milk/day during P1 and 6 liters of milk/day during P2 + 3.3 g of HMTBa/day in both periods. HMTBa was supplied in milk, and the amount of concentrated ration and hay provided and leftovers were recorded daily to estimate dry matter (DM) and crude protein consumption. Mean daily weight gain (DWG), final weight (FW), and feed conversion (FC) were obtained at the beginning and at the end of each 21-d period. Plasma concentrations of ghrelin and leptin, triglycerides, total protein, urea, lactate, creatinine, alkaline phosphatase, and cholesterol were measured for P1 and P2 at the end of each 21-d period. At the end of P2, animals were slaughtered; sections of the duodenum were collected to evaluate the expression of GHS-R1a and quantity of goblet cells; hypothalamus was used to evaluate the expression of GHS-R1a; rumen was used to evaluate the thickness of epithelium and keratin and the density, height, and width of ruminal papillae. In P1, total DM consumption, FW, DWG, glucose, and triglycerides were lower in the RES and RES + HMTBa groups (P < 0.001). In P2, there was an improvement in the FC of the RES + HMTBa group (compared with Control and RES groups) and a lower urea concentration in the RES group (compared with Control and RES + HMTBa groups) (P < 0.001). No differences were observed among groups regarding hormonal concentrations, histological parameters, and GHS-R1a expression in the duodenum and hypothalamus. Therefore, milk restriction combined with HMTBa supplementation promoted greater compensatory gain by a mechanism independent of changes in GHS-R1a expression and hormone levels of ghrelin and leptin.

Brain and kidney GHS-R1a underexpression is associated with changes in renal function and hemodynamics during neurogenic hypertension.

Ghrelin is a peptide hormone whose effects are mediated by the growth hormone secretagogue receptor subtype 1a (GHS-R1a), mainly expressed in the brain but also in kidneys. The hypothesis herein raised is that GHS-R1a would be player in the renal contribution to the neurogenic hypertension pathophysiology. To investigate GHS-R1a role on renal function and hemodynamics, we used Wistar (WT) and spontaneously hypertensive rats (SHR). First, we assessed the effect of systemically injected vehicle, ghrelin, GHS-R1a antagonist PF04628935, ghrelin plus PF04628935 or GHS-R1a synthetic agonist MK-677 in WT and SHR rats housed in metabolic cages (24 h). Blood and urine samples were also analyzed. Then, we assessed the GHS-R1a contribution to the control of renal vasomotion and hemodynamics in WT and SHR. Finally, we assessed the GHS-R1a levels in brain areas, aorta, renal artery, renal cortex and medulla of WT and SHR rats using western blot. We found that ghrelin and MK-677 changed osmolarity parameters of SHR, in a GHS-R1a-dependent manner. GHS-R1a antagonism reduced the urinary Na+ and K+ and creatinine clearance in WT but not in SHR. Ghrelin reduced arterial pressure and increased renal artery conductance in SHR. GHS-R1a protein levels were decreased in the kidney and brain areas of SHR when compared to WT. Therefore, GHS-R1a role in the control of renal function and hemodynamics during neurogenic hypertension seem to be different, and this may be related to brain and kidney GHS-R1a downregulation.

Milk restriction or oligosaccharide supplementation in calves improves compensatory gain and digestive tract development without changing hormone levels.

We estimated the effect of oligosaccharide supplementation and feed restriction on calves. The study was divided into two experimental periods of 28 days each with 20 crossbred calves that had initial body weight of 37 Kg and housed in individual pens. The animals were split in four experimental groups: animals fed 6 L milk/day (CON) in the two periods, animals fed milk restricted (3 L milk/day) in the first period and followed by CON feeding in the second period (RES), animals receiving supplementation of 5 g/day of mannanoligosaccharide (MOS) and animals receiving supplementation of 5 g/day mannan and frutoligosaccharide (MFOS). At the end of the study, all the animals were slaughtered. The average weight gain was lower in the restricted group when compared with CON and MFOS groups in the first period (P < 0.05) and there were no difference among the groups in the second period. Animals supplemented with MOS showed a significant increases in jejunal villus height and rumen papillae, which were not observed for MFOS group (P < 0.05) compared with RES and CON groups. There were no difference in ghrelin and leptin levels among treatments during periods 1 and 2 (P > 0.05). Also, the expression of ghrelin receptors in the paraventricular region of the hypothalamus did not differ among groups. We conclude that milk restriction during the first weeks of life in calves resulted in compensatory gain and did not modify the hormonal profile and expression of the ghrelin receptor in the hypothalamus. Moreover, a prebiotic supplementation changed the development of intestinal and ruminal epithelium.

Involvement of GABAergic and Adrenergic Neurotransmissions on Paraventricular Nucleus of Hypothalamus in the Control of Cardiac Function.

Sympathetic premotor neurons of the paraventricular hypothalamus (PVN) play a role in hemodynamics adjustments during changes in body fluid homeostasis. However, PVN contribution to the tonic control of cardiac function remains to be systematically studied. In this study, we assessed whether GABAergic and adrenergic synapses, known for being active in the PVN, are involved in the control of cardiac function. Adult male Wistar rats (250-350 g; n = 27) were anesthetized with urethane (1.2-1.4 g/kg i.p.) and underwent catheterization of femoral artery to record blood pressure and heart rate. The femoral vein was used to inject the vasoactive agents phenylephrine (10 µg/kg) and sodium nitroprusside (10 µg/kg) and to supplement anesthesia. The cardiac left ventricle was catheterized to record left ventricular pressure and its derivative. Craniotomy allowed for injections (100 nL) into the PVN of: muscimol (20 mM), bicuculline methiodide (0.4 mM), propranolol (10 mM), isoproterenol (100 µM), phentolamine (13 mM), phenylephrine (30 nM). We found that: (i) inhibition of PVN by muscimol, reduced arterial pressure, cardiac chronotropy and inotropy; (ii) disinhibition of PVN neurons by bicuculline evoked positive chronotropy and inotropy, and increase blood pressure; (iii) PVN alpha adrenergic receptors control cardiac chronotropy and inotropy; (iv) beta adrenergic receptors of the PVN do not influence cardiac function; (v) afterload does not contribute to the PVN-evoked inotropy. Our results indicate that the modulation of the activity of PVN neurons exerted by GABAergic and adrenergic mechanisms contribute to the control of cardiac function.

Ghrelin potentiates cardiac reactivity to stress by modulating sympathetic control and beta-adrenergic response.

Prior evidence indicates that ghrelin is involved in the integration of cardiovascular functions and behavioral responses. Ghrelin actions are mediated by the growth hormone secretagogue receptor subtype 1a (GHS-R1a), which is expressed in peripheral tissues and central areas involved in the control of cardiovascular responses to stress. AIMS: In the present study, we assessed the role of ghrelin - GHS-R1a axis in the cardiovascular reactivity to acute emotional stress in rats. MAIN METHODS AND KEY FINDINGS: Ghrelin potentiated the tachycardia evoked by restraint and air jet stresses, which was reverted by GHS-R1a blockade. Evaluation of the autonomic balance revealed that the sympathetic branch modulates the ghrelin-evoked positive chronotropy. In isolated hearts, the perfusion with ghrelin potentiated the contractile responses caused by stimulation of the beta-adrenergic receptor, without altering the amplitude of the responses evoked by acetylcholine. Experiments in isolated cardiomyocytes revealed that ghrelin amplified the increases in calcium transient changes evoked by isoproterenol. SIGNIFICANCE: Taken together, our results indicate that the Ghrelin-GHS-R1a axis potentiates the magnitude of stress-evoked tachycardia by modulating the autonomic nervous system and peripheral mechanisms, strongly relying on the activation of cardiac calcium transient and beta-adrenergic receptors.

Recentes avanços no tratamento da anemia falciforme / Recent advances in the sickle cell anemia treatment

A anemia falciforme é a doença monogênica de maior ocorrência mundial e é causada pela presença de hemoglobina S (HbS), uma variante estrutural decorrente da substituição de um aminoácido na cadeia ß globina. Essa mutação altera as propriedades bioquímicas e fisiológicas da hemoglobina, que tem a tendência de formar agregados fibrilares, no estado desoxigenado, o que produz alterações morfológicas (falcização) e funcionais da hemácia. Assim, todas as manifestações clínicas observadas na doença decorrem da presença da HbS e têm início com a hemólise e a vaso-oclusão, desencadeando os demais eventos da doença, que podem afetar os órgãos e sistemas orgânicos. O tratamento baseia-se no controle dos sintomas. O único medicamento aprovado que altera o curso da doença é o antineoplásico hidroxiureia e, apesar de seu sucesso clínico, não é curativo e pode desencadear muitos efeitos adversos. O único tratamento curativo é o transplante de células tronco hematopoéticas. A terapia gênica vem sendo estudada há mais de 30 anos e alguns estudos clínicos estão sendo realizados. Novas abordagens moleculares como a edição do genoma, uso de RNA terapêutico e manipulação genética para indução da síntese de hemoglobina fetal emergem como possibilidades para a cura da doença. (AU)

Sickle cell anemia is the most common monogenic disease worldwide and it is caused by the presence of sickle hemoglobin (HbS), structural variant hemoglobin with one amino acid substitution in the ß globin chain. This mutation changes the biochemical and physiological properties of hemoglobin, which has the tendency, in the de-oxygenated state, to form fibrous aggregates, which produces morphological (sickling) and functional changes in red blood cells. Thus, all the observed disease clinical manifestations arise from the presence of HbS and begin with hemolysis of the red blood cell and vaso-occlusion, triggering other disease events, which can affect the body organs and systems as a whole. Nowadays, treatment is based mainly in symptoms control. The only drug approved that changes the course of the disease is the antineoplastic Hydroxyurea and, despite its clinical success, it is not curative and can trigger many adverse effects. The only curative treatment is the hematopoietic stem cells transplantation. Gene therapy has been studied for more than 30 years and some clinical studies are being in course. New molecular approaches as the genome editing, therapeutic RNA and genetic manipulation to stimulate fetal hemoglobin synthesis emerge as possible curative options for the disease. (AU)

Bone Marrow-Derived Stem Cell Populations Are Differentially Regulated by Thyroid or/and Ovarian Hormone Loss.

Bone marrow-derived stem cells (BMDSCs) play an essential role in organ repair and regeneration. The molecular mechanisms by which hormones control BMDSCs proliferation and differentiation are unclear. Our aim in this study was to investigate how a lack of ovarian or/and thyroid hormones affects stem cell number in bone marrow lineage. To examine the effect of thyroid or/and ovarian hormones on the proliferative activity of BMDSCs, we removed the thyroid or/and the ovaries of adult female rats. An absence of ovarian and thyroid hormones was confirmed by Pap staining and Thyroid Stimulating Hormone (TSH) measurement, respectively. To obtain the stem cells from the bone marrow, we punctured the iliac crest, and aspirated and isolated cells by using a density gradient. Specific markers were used by cytometry to identify the different BMDSCs types: endothelial progenitor cells (EPCs), precursor B cells/pro-B cells, and mesenchymal stem cells (MSCs). Interestingly, our results showed that hypothyroidism caused a significant increase in the percentage of EPCs, whereas a lack of ovarian hormones significantly increased the precursor B cells/pro-B cells. Moreover, the removal of both glands led to increased MSCs. In conclusion, both ovarian and thyroid hormones appear to have key and diverse roles in regulating the proliferation of cells populations of the bone marrow.

Production and chemical composition of hybrid Brachiaria cv. Mulato II under a system of cuts and nitrogen fertilization / Produção e composição bromatológica da Brachiaria híbrida cv. Mulato II sob regime de cortes e adubação nitrogenada

The production capacity of green and dry mass of the entire plant, efficiency of N conversion, apparent N recovery and the chemical composition of cultivar Mulato II was evaluated under a system of cuts and nitrogen doses. The assay, conducted in the municipality of Goiânia, GO, Brazil, had a totally randomized 2 x 4 factorial design (2 height cuts, 0.40 and 0.50 m and 4 nitrogen doses), with three replications and subdivided subplots. Treatments comprised four N doses (0, 50, 100 and 150 kgha-1 N, with urea as nitrogen source). There was no significant interaction (p>0.05) between N doses and cut heights for the variables productivity of green (PGM) and dry (PDM) mass, nitrogen use efficiency (NUE) and apparent N recovery (ANR), which were neither affected (p<0.05) by N doses nor by evaluated cut heights. Average productivity reached 59,450 kgha-1 (PGV) and 10,367 kgha-1 (PDM) and it was produced an average of 19.62 kg of DM per kg of N, with a mean 56.00% recovery. N doses and cut heights did not affect (p>0.05) DM rates of the plant, whilst mean dry matter rate was 17.49%. CP rates were affected (p<0.05) by N doses (0, 50, 100 and 150 kgha-1) and cut heights (0.40 and 0.50 m) and by the interaction of these factors. CP rates of the entire plant hybrid Brachiaria cv. Mulato II increased (p<0.05) due to N doses through an increasing linear relationship. Since there was a significant effect (p<0.05) with regard to cut height and CP rates decreased with height increase. NDF rates were significantly influenced by N doses (p<0.05) and by cut heights (p<0.05), with significance for the interaction (p<0.05) of over 100 kgha-1 N doses only. No significant interaction (p>0.05) occurred in ADF rates among the variables analyzed. ADF contents were influenced by N supply (p<0.05) with decreasing quadratic regression as N doses increased.

O presente trabalho de pesquisa teve como objetivo avaliar o potencial produtivo de massa verde e seca da planta inteira, a eficiência de conversão do N, a recuperação aparente do N, bem como a composição bromatológica do cultivar Mulato II, sob regime de cortes e submetido a doses de nitrogênio, no município de Goiânia, GO, Brasil. Utilizou-se um delineamento experimental inteiramente casualizado com arranjo fatorial 2 X 4 (2 alturas de corte (0,40 e 0,50 m) X 4 doses de nitrogênio) com três repetições e parcelas subdivididas. Os tratamentos foram constituídos por quatro doses de N (0, 50, 100 e 150 kgha-1 de N) (sendo a fonte ureia). Não ocorreu interação significativa (p>0,05) entre doses de N e alturas de corte para as variáveis produtividades de massa verde (PMV) e massa seca (PMS), eficiência de conversão aparente de nitrogênio (ECAN) e recuperação aparente de nitrogênio (RAN), que não foram influenciadas (p<0,05) pelas doses de N, nem em função das alturas de corte avaliadas. A média de produtividade encontrada foi de 59.450 kgha-1 (PMV) e 10.367 kgha-1 (PMS), produzindo em média 19,62 kg de MS para cada kg de N aplicado, com uma recuperação média de 56,00%. As doses de N aplicadas e as alturas de corte não influenciaram (p>0,05) os teores de MS da planta. A média do teor de matéria seca encontrada foi de 17,49%. Os teores de PB foram influenciados (p<0,05) pelas doses de N (0, 50, 100 e 150 kgha-1) e alturas de corte (0,40 e 0,50 m) bem como a interação desses fatores. Os teores de proteína bruta (PB) da planta inteira Brachiaria híbrida cv. Mulato II aumentaram (p<0,05) em função das doses de N, apresentando uma relação linear crescente. Quanto à altura de corte, ocorreu também efeito significativo (p<0,05), evidenciando que os teores de PB diminuíram com o aumento da altura. Os teores de FDN foram influenciados significativamente pelas doses de N (p<0,05) e pelas alturas de corte (p<0,05), apresentando significância para a interação (p<0,05) apenas nas doses acima de 100 kgha-1 de N. Para os teores de FDA não houve interação significativa (p>0,05) entre as variáveis analisadas. O conteúdo de FDA foi influenciado pelo fornecimento de N (p<0,05), apresentando regressão quadrática decrescente com o aumento das doses de N.

Human Adipose-Derived Mesenchymal Stem Cells Cryopreservation and Thawing Decrease α4-Integrin Expression.

Aim. The effects of cryopreservation on adipose tissue-derived mesenchymal stem cells are not clearly documented, as there is a growing body of evidence about the importance of adipose-derived mesenchymal stem cells for regenerative therapies. The aim of this study was to analyze human adipose tissue-derived mesenchymal stem cells phenotypic expression (CD34, CD45, CD73, CD90, CD105, and CD49d), colony forming unit ability, viability, and differentiation potential before and after cryopreservation. Materials and Methods. 12 samples of the adipose tissue were collected from a healthy donor using the liposuction technique. The cell isolation was performed by enzymatic digestion and then the cells were cultured up to passage 2. Before and after cryopreservation the immunophenotype, cellular viability analysis by flow cytometer, colony forming units ability, differentiation potential into adipocytes and osteoblasts as demonstrated by Oil Red O and Alizarin Red staining, respectively. Results. The immunophenotypic markers expression was largely preserved, and their multipotency was maintained. However, after cryopreservation, the cells decreased α4-integrin expression (CD49d), cell viability, and number of colony forming units. Conclusions. These findings suggest that ADMSC transplanted after cryopreservation might compromise the retention of transplanted cells in the host tissue. Therefore, further studies are warranted to standardize protocols related to cryopreservation to attain full benefits of stem cell therapy.

Animal performance and carcass characteristics from confined lambs fed on concentrate feed and additives.

The number of sheep flocks in Brazil is increasing. It is known that lambs must be slaughtered when young for producing quality meat. The current study evaluated the inclusion of protected methionine, protected lysine, lysophospholipid and amylolytic enzymes in a diet to lambs and their effects on weight gain and quantitative carcass traits at slaughtering. Eighty non-castrated male crossbred Dorper x Santa Inês lambs, 20.57 ± 4.33 kg live weight, were used. The feedlot lasted 64 days and 60 animals were slaughtered. There were no differences for live weight, daily feed intake, feed conversion and average daily weight gain at the first 28 days of feedlot. From the 28th day lysophospholipid treatment presented the highest live weight. Lysophospholipid and amylolytic enzyme presented the best performance in average daily gain, followed by protected methionine, control and protected lysine. Lysophospholipid treatment presented higher daily feed intake rates than protected lysine and protected methionine. Feed conversion was lower for amylolytic enzyme and higher for control. No changing in carcass traits was reported due to additives. Better performance may be achieved with feedlot lambs fed on diets with the addition of amylolytic enzyme and lysophospholipid at the finishing phase.

Self-assembled films containing crude extract of avocado as a source of tyrosinase for monophenol detection.

This paper reports on the use of the crude extract of avocado (CEA) fruit (Persea americana) as a source of tyrosinase enzyme. CEA was immobilized via layer by layer (LbL) technique onto indium tin oxide (ITO) substrates and applied in the detection of monophenol using a potentiometric biosensor. Poly(propylene imine) dendrimer of generation 3 (PPI-G3) was used as a counter ion in the layer by layer process due to its highly porous structure and functional groups suitable for enzyme linkage. After the immobilization of the crude CEA as multilayered films, standard samples of monophenol were detected in the 0.25-4.00 mM linear range with approximately 28 mV mM(-1) of sensitivity. This sensitivity is 14 times higher than the values found in the literature for a similar system. The results show that it is possible to obtain efficient and low-cost biosensors for monophenol detection using potentiometric transducers and alternative sources of enzymes without purification.

Preclinical stem cell therapy in Chagas Disease: Perspectives for future research.

Chagas cardiomyopathy still remains a challenging problem that is responsible for high morbidity and mortality in Central and Latin America. Chagas disease disrupts blood microcirculation via various autoimmune mechanisms, causing loss of cardiomyocytes and severe impairment of heart function. Different cell types and delivery approaches in Chagas Disease have been studied in both preclinical models and clinical trials. The main objective of this article is to clarify the reasons why the benefits that have been seen with cell therapy in preclinical models fail to translate to the clinical setting. This can be explained by crucial differences between the cellular types and pathophysiological mechanisms of the disease, as well as the differences between human patients and animal models. We discuss examples that demonstrate how the results from preclinical trials might have overestimated the efficacy of myocardial regeneration therapies. Future research should focus, not only on studying the best cell type to use but, very importantly, understanding the levels of safety and cellular interaction that can elicit efficient therapeutic effects in human tissue. Addressing the challenges associated with future research may ensure the success of stem cell therapy in improving preclinical models and the treatment of Chagas disease.

Controversies about the chromosomal stability of cultivated mesenchymal stem cells: their clinical use is it safe?

The usefulness of adult stem cells in research and therapeutic applications highly relies on their genomic integrity and stability. Many laboratories including ours have addressed this concern using methods such as karyotyping, Qbanding, fluorescent in situ hybridization, array CGH, flow cytometry and Pap test to evaluate number and structure of chromosomes and cellular phenotype. This review attempts to summarize the findings reported so far for the studies on chromosomal aberrations in adult stem cells and warrant to perform certain basic tests before transplantation to avoid any adverse reactions, which will thus aid in better therapeutic output after cellular transplantation in the treatment of various diseases.

Aspectos biológicos e atividade tumorigênica da família proto-oncogênica Ras / Biological aspects and tumorigenic activity of the Ras proto-oncogenic Family

Os proto-oncogenes desempenham importante papel na regulação do ciclo celular, e são críticos à tumorigênese. Nessa categoria se encontra a família RAS, que, devido ao elevado potencial transformante dos genes que a compõem, é uma das mais bem descritas e estudadas. É formada pelos genes H-, K- e N-RAS, que codificam proteínas altamente relacionadas expressas em vários tipos de células, denominadas p21. Estas atuam na transdução de sinal da membrana ao núcleo, estão envolvidas no controle da proliferação, diferenciação e morte celular e são reguladas pela interação com GDP (inativa) e GTP (ativa). As proteínas p21 diferem em apenas 10-15% da sua estrutura primária, na porção C-terminal, denominada região hipervariante. Quando na forma oncogênica, permanecem ativas, e conferem estímulo contínuo à proliferação celular. Dentre os genes RAS, K-RAS tem sido o mais estudado, por apresentar mutações mais freqüentes e presentes em tumores mais agressivos, e implicar em menor sobrevida aos pacientes. Pelo importante papel já demonstrado na formação de tumores e relativa carência de bibliografia em língua portuguesa acerca dessa família gênica, apresentamos neste trabalho uma revisão sistematizada e atualizada sobre os proto-oncogenes RAS.

Proto-oncogenes play an important role in the regulation of the cellular cycle, being critical to the tumorigenesis. In this category we can find the RAS family. Due to the high transformation potential of these genes, this family is the best described and most studied one. It is formed by the H-, K- and the N-RAS genes, that codify highly related proteins expressed in several types of cells, denominated p21.These proteins act in the sign transduction from the membrane to the nucleus, as well as in the control of proliferation, differentiation and cellular death, and they are regulated by the interaction with GDP (inactive) and GTP (active). These proteins show variation in only 10 - 15% of the primary structure, in the C-terminal portion denominated hyper-variant region. When in the oncogenic form, the p21 proteins remain active, providing continuous stimuli to the cellular proliferation. Among the RAS genes, K-RAS ones have been the most studied for presenting more frequent mutations and for being present in more aggressive tumors, implying the patients’ shorter survival time. Due to these facts and relative bibliography lack in the Portuguese language on this family, we presented in this work a systematized and updated review on the RAS genes.

Central activities of hydroalcoholic extract from Lafoensia pacari A. St.-Hil. stem bark / Atividades centrais do extrato de Lafoensia pacari A. St.- Hil. da casca do caule

Lafoensia pacari A. St.-Hil. can be found from Amapá to Rio Grande do Sul states, and also in Paraguay and Bolivia. It is popularly known as pacari or mangava-brava and is used to promote weight loss, as an anti-thermal or tonic, to treat gastritis, ulcers, scarring, itching, discouragement, and cancer. In the open field tests, the hydroalcoholic extract from L. pacari stem bark (HEP) decreased the number of rearings, number of invaded squares, and increased immobility time compared to control animals. In the pentobarbital-induced sleep time test, HEP decreased latency time to sleep and increased sleeping time. In the rota-rod test, no changes in the studied parameters were observed. In the elevated plus maze, HEP increased the percentage time and percentage entries in the open arms, indicating that this extract exerts an anxiolytic-like activity.

Lafoensia pacari A. St.-Hil., uma espécie vegetal presente no Brasil, do Amapá ao Rio Grande do Sul, no Paraguai e na Bolívia, é popularmente conhecida como pacari ou mangava-brava e é utilizada como emagrecedor, cicatrizante, antitérmico, tônico e para tratar gastrite, úlcera, coceira, desânimo e câncer. No teste do campo aberto, o tratamento com o extrato hidro-alcoólico de pacari (HEP) reduziu o número de rearings e o número de quadrados invadidos além de aumentar o tempo de imobilidade dos animais em relação ao controle. No sono induzido por pentobarbital sódico o tratamento com HEP causou redução na latência e aumento na duração do sono. No rota-rod, o tratamento com HEP não alterou os parâmetros observados. No teste de labirinto em cruz elevado, com o tratamento com HEP foi observado aumento do percentual do tempo de permanência e de entradas nos braços abertos, caracterizando uma atividade tipo ansiolítica.

Avaliação dos efeitos do tratamento com zinco orgânico sobre a reprodução e no comportamento de ratas (Rattus norvegicus) / Evaluation of the organic zinc treatment effects in female rat (Rattus norvegicus) reproduction and behaviour / Evaluación de los efectos del tratamiento con zinc orgánico sobre la reproducción y comportamiento de ratas (rattus norvegicus)

O objetivo do presente trabalho foi avaliar o efeito do tratamento com zinco orgânico no desempenho reprodutivo e no comportamento, por meio de testes de natação forçada, campo aberto e sono induzido por barbitúrico. Foram utilizadas 21 ratas Wistar (Rattus norvegicus), distribuídas em três grupos de sete animals cada, acomodadas em caixas individuais, submetidas a diferentes tratamentos: SZn (controle - sem zinco); ZnP (zinco na forma quelada, por via intramuscular); ZnO (zinco orgânico na dieta, 5 mg/kg). Não foram observadas diferenças estatísticas entre os tratamentos SZn (10,4 ± 2,4 filhotes), ZnP (6,9 ± 2,6 filhotes) e ZnO (3,3 ± 2,6 filhotes), com relação ao desempenho reprodutivo. No teste de desespero comportamental, os tempos de imobilidade dos animals tratados com SZn (91,1 ± 15 seg.), ZnP (71,2 ± 17 seg.) e ZnO (79,9 ± 20 seg.) não apresentaram diferenças estatísticas (p > 0,05). Na avaliação hipno-sedativa, não foram observadas diferenças estatísticas (p > 0,05) no tempo de indução (SZn = 6,6 ± 2; ZnP = 5,3 ± 2; ZnO = 3,6 ± 0,3 min.), nem no tempo de recuperação (SZn = 295 ± 15; ZnP = 320 ± 34; ZnO = 355 ± 38 min.). Os outros parâmetros comportamentais avaliados (número de levantamentos, auto-limpeza, tempo na periferia e número de quadrados invadidos) também não foram influenciados (p > 0,05). Concluiu-se que o zinco, na forma orgânica, administrado via parenteral ou oral, não influencia a reprodução nem o comportamento de ratas.

This article aims at evaluating the effects of the organic zinc treatment over the reproductive performance and behavior through forced swimming tests, open field, and barbiturate-induced sleep. 21 female Wistar rats (Rattus norvegicus) were used, distributed into three groups of seven animals, placed in individual boxes, and submitted to different treatments: SZn (control- without zinc), ZnP (zinc for intramuscular administration), and ZnO (organic zinc in the diet, 5 mg/kg). Statistic differences were not observed (p> 0,05) among the treatments SZn (10.4 ± 2.4 nestlings), ZnP (6.9 ± 2.6 nestlings), and ZnO (3.3 ± 2.6 nestlings), in relation to the number ofnestlings. In the behavioral despair test, the immobility time of the animals treated with SZn (91.1 ± 15 seg.), ZnP (71.2 ± 17 seg.), and ZnO (79.9 ± 20 seg) did not present any statistic differences (p > 0,05). Statistic differences (p> 0,05) were neither present at the induction time (SZn = 6.6 ± 2; ZnP = 5.3 ± 2; ZnO = 3.6 ± 0.3 min), nor in the recovery time (SZn = 295 ± 15; ZnP = 320 ± 34; ZnO = 355 ± 38 min) at the hypno-sedative evaluation. The other behavioral parameters evaluated (number of risings, self-cleaning, time in the periphery, and number of invaded squares) were not altered as well. It was concluded that zinc, in its organic form, either parenterally or orally administered, neither influences the reproduction nor the behavior of female rats.

Aspectos biológicos e moleculares da Adrenoleucodistrofia / Biological and molecular aspects of Adrenoleukodystrophy

Esta revisão aborda as principais descobertas sobre a Adrenoleucodistrofia ligada ao cromossomo X (X-ALD), correlacionando informações moleculares e clínicas, oferecendo subsídios para maior compreensão desta patologia. A X-ALD é a mais freqüente patologia humana decorrente de desordem peroxissomal com freqüência de 1:20.000 meninos. É uma herança recessiva ligada ao sexo, com seu gene ocupando o locus Xq28. A desmielinização, ou seja, a solubilização da bainha de mielina é uma conseqüência da doença, os pacientes desenvolvem os sintomas, como, convulsão, atrofia adrenal e fibrose hepática, geralmente até os 10 anos de idade. A doença tem rápida progressão, culminando em morte, em média, até cinco anos após o aparecimento dos sintomas. A forma atual de tratamento consiste restrição alimentar de ácidos graxos combinada à ingestão de gliceroltrioléico e gliceroltrieructado na proporção de 4:1 (Óleo de Lorenzo). Também o transplante de medula óssea e a imunossupressão foram propostos como alternativas terapêuticas, porém, sem possibilitar a cura dos pacientes...

Aspectos biológicos, genéticos e moleculares do gene BCR-ABL e sua relação com a Leucemogênese / Biological, genetic and molecular aspects of the BCR-ABL gene and its relationship with Leukemogenesis

O Cromossomo Philadelphia (Ph1) é conhecido como a primeira alteração cromossômica estrutural (translocação recíproca) envolvida em um tipo de câncer específico, sendo por este motivo, o mais bem caracterizado rearranjo cromossômico ligado à origem de leucemias. Sua origem está na translocação recíproca t(9;22), envolvendo o proto-oncogene ABL (9q34) e o gene BCR (22q11). A fusão destes genes forma o oncogene quimérico BCR-ABL, conhecido atualmente como marcador molecular da leucemia mielóide crônica (LMC), e apontado como fator significante na leucemogênese. A simples presença deste híbrido já é suficiente para conduzir a célula ao fenótipo neoplásico, contrariando estudos epidemiológicos referentes à gênese de cânceres. Diferentes pontos de quebra no gene BCR acabam produzindo transcritos de diferentes tamanhos, que codificam vários produtos quiméricos, como p190bcr-abl, p210bcr-abl e p230bcr-abl. A atuação destas proteínas parece estar ligada aos diferentes fenótipos leucêmicos, sendo responsáveis por modificações em vias intracelulares, como da proteína Ras, aquisição de fatores de crescimento, resistência ao processo de morte celular programada e desequilíbrio celular, promovendo a instabilidade genômica em células Ph1-positivas...